Key result
Polygenic Mendelian randomization for vitamin D yields contrasting CVD results compared to focused genetic instruments.
Why the study?
Does the choice of genetic variants (polygenic vs focused) affect Mendelian randomization findings for vitamin D and cardiovascular disease?
Observational
Does the choice of genetic variants (polygenic vs focused) affect Mendelian randomization findings for vitamin D and cardiovascular disease?
Answers are grounded in this paper and cite their sources.
The choice of genetic variants (polygenic vs focused) is critical and leads to contrasting findings in Mendelian randomization studies evaluating vitamin D and cardiovascular disease.
Contrasting findings from Mendelian randomization analyses performed using a polygenic choice of genetic variants (that is, all genome-wide significant predictors of 25-hydroxyvitamin D) to those using a focused choice of genetic variants (that is, variants in four gene regions related to vitamin D synthesis and metabolism). Contrasting findings from Mendelian randomization analyses performed using a polygenic choice of genetic variants (that is, all genome-wide significant predictors of 25-hydroxyvitamin D) to those using a focused choice of genetic variants (that is, variants in four gene regions related to vitamin D synthesis and metabolism).
No takes yet. Share an insight, caveat, or question.
Burgess et al. (2021) conducted an observational in Cardiovascular disease. 25-hydroxyvitamin D genetic variants vs. Focused vs polygenic choice of variants was evaluated. Mendelian randomization analyses using a polygenic choice of genetic variants for 25-hydroxyvitamin D yielded contrasting findings compared to those using a focused choice of genetic variants.
Synapse has enriched 10 related papers. Consider them for comparative context: